Literature DB >> 22971345

Endoneurial macrophages induce perineural invasion of pancreatic cancer cells by secretion of GDNF and activation of RET tyrosine kinase receptor.

Oren Cavel1, Olga Shomron, Ayelet Shabtay, Joseph Vital, Leonor Trejo-Leider, Noam Weizman, Yakov Krelin, Yuman Fong, Richard J Wong, Moran Amit, Ziv Gil.   

Abstract

Perineural invasion of cancer cells (CPNI) is found in most patients with pancreatic adenocarcinomas (PDA), prostate, or head and neck cancers. These patients undergo palliative rather than curative treatment due to dissemination of cancer along nerves, well beyond the extent of any local invasion. Although CPNI is a common source of distant tumor spread and a cause of significant morbidity, its exact mechanism is undefined. Immunohistochemical analysis of specimens excised from patients with PDAs showed a significant increase in the number of endoneurial macrophages (EMΦ) that lie around nerves invaded by cancer compared with normal nerves. Video microscopy and time-lapse analysis revealed that EMΦs are recruited by the tumor cells in response to colony-stimulated factor-1 secreted by invading cancer cells. Conditioned medium (CM) of tumor-activated EMΦs (tEMΦ) induced a 5-fold increase in migration of PDA cells compared with controls. Compared with resting EMΦs, tEMΦs secreted higher levels of glial-derived neurotrophic factor (GDNF), inducing phosphorylation of RET and downstream activation of extracellular signal-regulated kinases (ERK) in PDA cells. Genetic and pharmacologic inhibition of the GDNF receptors GFRA1 and RET abrogated the migratory effect of EMΦ-CM and reduced ERK phosphorylation. In an in vivo CPNI model, CCR2-deficient mice that have reduced macrophage recruitment and activation showed minimal nerve invasion, whereas wild-type mice developed complete sciatic nerve paralysis due to massive CPNI. Taken together, our results identify a paracrine response between EMΦs and PDA cells that orchestrates the formation of cancer nerve invasion. ©2012 AACR.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22971345     DOI: 10.1158/0008-5472.CAN-12-0764

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  54 in total

Review 1.  How Schwann cells facilitate cancer progression in nerves.

Authors:  Sylvie Deborde; Richard J Wong
Journal:  Cell Mol Life Sci       Date:  2017-06-19       Impact factor: 9.261

2.  Impact of GFRA1 gene reactivation by DNA demethylation on prognosis of patients with metastatic colon cancer.

Authors:  Wan-Ru Ma; Peng Xu; Zhao-Jun Liu; Jing Zhou; Lian-Kun Gu; Jun Zhang; Da-Jun Deng
Journal:  World J Gastroenterol       Date:  2020-01-14       Impact factor: 5.742

3.  Inflammatory Monocytes Promote Perineural Invasion via CCL2-Mediated Recruitment and Cathepsin B Expression.

Authors:  Richard L Bakst; Huizhong Xiong; Chun-Hao Chen; Sylvie Deborde; Anna Lyubchik; Yi Zhou; Shizhi He; William McNamara; Sei-Young Lee; Oakley C Olson; Ingrid M Leiner; Andrea R Marcadis; James W Keith; Hikmat A Al-Ahmadie; Nora Katabi; Ziv Gil; Efsevia Vakiani; Johanna A Joyce; Eric Pamer; Richard J Wong
Journal:  Cancer Res       Date:  2017-09-26       Impact factor: 12.701

4.  Promoter CpG island methylation of RET predicts poor prognosis in stage II colorectal cancer patients.

Authors:  Muriel X G Draht; Kim M Smits; Benjamin Tournier; Valerie Jooste; Caroline Chapusot; Beatriz Carvalho; Arjen H G Cleven; Sarah Derks; Kim A D Wouters; Eric J T Belt; Hein B A C Stockmann; Herman Bril; Matty P Weijenberg; Piet A van den Brandt; Adriaan P de Bruïne; James G Herman; Gerrit A Meijer; Françoise Piard; Veerle Melotte; Manon van Engeland
Journal:  Mol Oncol       Date:  2014-02-02       Impact factor: 6.603

5.  Ablation of sensory neurons in a genetic model of pancreatic ductal adenocarcinoma slows initiation and progression of cancer.

Authors:  Jami L Saloman; Kathryn M Albers; Dongjun Li; Douglas J Hartman; Howard C Crawford; Emily A Muha; Andrew D Rhim; Brian M Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-29       Impact factor: 11.205

Review 6.  RET revisited: expanding the oncogenic portfolio.

Authors:  Lois M Mulligan
Journal:  Nat Rev Cancer       Date:  2014-03       Impact factor: 60.716

7.  CD13hi Neutrophil-like myeloid-derived suppressor cells exert immune suppression through Arginase 1 expression in pancreatic ductal adenocarcinoma.

Authors:  Jing Zhang; Xiongfei Xu; Min Shi; Ying Chen; Danghui Yu; Chenyan Zhao; Yan Gu; Biao Yang; Shiwei Guo; Guiling Ding; Gang Jin; Chin-Lee Wu; Minghua Zhu
Journal:  Oncoimmunology       Date:  2017-01-09       Impact factor: 8.110

8.  GDNF secreted by nerves enhances PD-L1 expression via JAK2-STAT1 signaling activation in HNSCC.

Authors:  Chengzhong Lin; Wei Cao; Zhenhu Ren; Yu Tang; Chunye Zhang; Rong Yang; Yiming Chen; Zheqi Liu; Canbang Peng; Lizhen Wang; Xu Wang; Tong Ji
Journal:  Oncoimmunology       Date:  2017-07-20       Impact factor: 8.110

9.  Upregulation of RET induces perineurial invasion of pancreatic adenocarcinoma.

Authors:  M Amit; S Na'ara; L Leider-Trejo; Y Binenbaum; N Kulish; E Fridman; A Shabtai-Orbach; R J Wong; Z Gil
Journal:  Oncogene       Date:  2017-01-16       Impact factor: 9.867

10.  GFRA1 promotes cisplatin-induced chemoresistance in osteosarcoma by inducing autophagy.

Authors:  Mihwa Kim; Ji-Yeon Jung; Seungho Choi; Hyunseung Lee; Liza D Morales; Jeong-Tae Koh; Sun Hun Kim; Yoo-Duk Choi; Chan Choi; Thomas J Slaga; Won Jae Kim; Dae Joon Kim
Journal:  Autophagy       Date:  2016-10-18       Impact factor: 16.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.